Exact Mass: 711.3301674
Exact Mass Matches: 711.3301674
Found 76 metabolites which its exact mass value is equals to given mass value 711.3301674,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Indinavir Sulfate
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
Monoaspartyl chlorin e6
C38H41N5O9 (711.2904136000001)
cyclopenta-1,3-diene,(1S)-1-(2-dicyclohexylphosphanylcyclopenta-2,4-dien-1-yl)-1-(2-dicyclohexylphosphanylphenyl)-N,N-dimethylmethanamine,iron(2+)
Talaporfin
C38H41N5O9 (711.2904136000001)
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000970 - Antineoplastic Agents C1420 - Photosensitizing Agent D003879 - Dermatologic Agents
(s)-(+)-[(r)-2-dicyclohexylphosphinoferrocenyl](n,n-dimethylamino)(2-dicyclohexylphosphinophenyl)methane
Monoaspartyl chlorin e6
C38H41N5O9 (711.2904136000001)
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000970 - Antineoplastic Agents D003879 - Dermatologic Agents
1-[(3S,9R,10R)-12-[(2S)-1-(dimethylamino)propan-2-yl]-9-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-phenylurea
N-(2-aminophenyl)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C38H48F3N5O5 (711.3607353999998)
N-(2-aminophenyl)-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C38H48F3N5O5 (711.3607353999998)
N-(2-aminophenyl)-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C38H48F3N5O5 (711.3607353999998)
N-(2-aminophenyl)-N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C38H48F3N5O5 (711.3607353999998)
N-(2-aminophenyl)-N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C37H47Cl2N5O5 (711.2954071999999)
N-(2-aminophenyl)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C38H48F3N5O5 (711.3607353999998)
N-(2-aminophenyl)-N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C37H47Cl2N5O5 (711.2954071999999)
N-(2-aminophenyl)-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C38H48F3N5O5 (711.3607353999998)
N-(2-aminophenyl)-N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C37H47Cl2N5O5 (711.2954071999999)
N-(2-aminophenyl)-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide
C38H48F3N5O5 (711.3607353999998)
LCKLSL (hydrochloride)
C30H58ClN7O8S (711.3755898000001)
LCKLSL hydrochloride is a N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor. LCKLSL hydrochloride potently inhibits the binding of tissue plasminogen activator (tPA) to AnxA2. LCKLSL hydrochloride also inhibits the generation of plasmin and has anti-angiogenic roles[1].
19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one
1-{[6-({2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carbonyloxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid
(?)-2α-acetoxy-2',7-dideacetoxy-1-hydroxy-11(15→1)-abeo-austrospicatine
{"Ingredient_id": "HBIN005259","Ingredient_name": "(?)-2\u03b1-acetoxy-2',7-dideacetoxy-1-hydroxy-11(15\u21921)-abeo-austrospicatine","Alias": "NA","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "157","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(+)-2alpha-acetoxy-2',7-dideacetoxy-1-hydroxy-austrospicatine
{"Ingredient_id": "HBIN005260","Ingredient_name": "(+)-2alpha-acetoxy-2',7-dideacetoxy-1-hydroxy-austrospicatine","Alias": "(+)-2\u03b1-acetoxy-2',7-dideacetoxy-1-hydroxy-austrospicatine","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "CC1=C2C(C(C3(CCC(C(=C)C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)OC(=O)CC(C4=CC=CC=C4)N(C)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "711.8 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25404;158","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5320472","DrugBank_id": "NA"}
2alpha-hydroxy-2'beta-deacetylaustrospicatine
{"Ingredient_id": "HBIN005282","Ingredient_name": "2alpha-hydroxy-2'beta-deacetylaustrospicatine","Alias": "2\u03b1-hydroxy-2'\u03b2-deacetylaustrospicatine","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31173;9958","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2'-deacetylaustrospicatine
{"Ingredient_id": "HBIN005503","Ingredient_name": "2'-deacetylaustrospicatine","Alias": "NA","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4717","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7beta-deacetylaustrospicatine
{"Ingredient_id": "HBIN013099","Ingredient_name": "7beta-deacetylaustrospicatine","Alias": "NA","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C2(C)C)CC1OC(=O)C)C(=C)C(CC3O)OC(=O)C(C(C4=CC=CC=C4)N(C)C)OC(=O)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26034","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-deacetylaustrospicatine
{"Ingredient_id": "HBIN013142","Ingredient_name": "7-deacetylaustrospicatine","Alias": "NA","Ingredient_formula": "C39H53NO11","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4718","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1r,3s,5r,6r,7z,11r,12s,13z,15z,17z,19z,21r,23s,24r,25s)-21-{[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-12-ethyl-1,3,5,6,25-pentahydroxy-11-methyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid
(2s,3as,4s,4ar,6s,8ar,9r,10r)-2,4,9,10-tetrakis(acetyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-6-yl (3r)-3-(dimethylamino)-3-phenylpropanoate
2,4,9,10-tetrakis(acetyloxy)-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-5-methylidene-2h,3h,4h,4ah,6h,7h,8h,9h,10h-cyclohexa[f]azulen-6-yl 3-(dimethylamino)-3-phenylpropanoate
(2s)-2-({[(1s)-1-{[(1s,2r)-2-[(2s)-2-amino-n-methylpropanamido]-1-({[(2z,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}amino)-3-(1h-indol-3-yl)propanoic acid
C32H41N9O10 (711.2976246000001)
(7s,9e,11s,12r,13s,14r,15r,16r,17s,18s,19e,21z)-2,15,17,23,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,26,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,23,25(29)-octaen-13-yl acetate
(2s,3s,3as,4r,6s,7s,8s,12r,13ar)-7-(acetyloxy)-4,12,13a-trihydroxy-2,9,9,12-tetramethyl-3,6-bis({[(2z)-2-methylbut-2-enoyl]oxy})-5-methylidene-13-oxo-1h,2h,3h,3ah,4h,6h,7h,8h-cyclopenta[12]annulen-8-yl pyridine-3-carboxylate
2,15,17,23,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,26,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,23,25(29)-octaen-13-yl acetate
(1s,4as,7as)-1-{[(2s,3r,4s,5s,6r)-6-{[(1r,2s,3r,5r,6s,10s,16r,17r)-2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carbonyloxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid
(7s,9e,11s,12r,13s,14r,15r,16s,17s,18e,20z,22s)-2,15,17,23,26,27-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30,31-trioxa-24-azapentacyclo[20.6.2.1⁴,⁷.0⁵,²⁸.0²⁵,²⁹]hentriaconta-1(29),2,4,9,18,20,23,25,27-nonaen-13-yl acetate
(1r,9s,10r,11s,13r,15s,16s,19s,20r,23r,24r,28s,29r,31r,32r,36s)-19-ethenyl-21,31,32,35-tetrahydroxy-11,13,15,17,19,26,28,29-octamethyl-8,30,33-trioxa-34-azanonacyclo[20.11.2.1³,⁷.1⁹,¹⁶.0¹,²³.0¹⁰,¹⁵.0²⁴,³².0²⁷,³¹.0²⁰,³⁶]heptatriaconta-3(37),4,6,17,21,26,34-heptaen-25-one
(1s,4as,7as)-1-{[(2s,3r,4s,5s,6r)-6-{[(1r,2s,3r,5s,6s,10s,16r,17r)-2,6-dimethyl-20-oxo-8-azahexacyclo[11.5.1.1¹,⁵.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]icos-13(19)-ene-17-carbonyloxy]methyl}-3,4,5-trihydroxyoxan-2-yl]oxy}-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-4-carboxylic acid
7-(acetyloxy)-4,12,13a-trihydroxy-2,9,9,12-tetramethyl-3,6-bis[(2-methylbut-2-enoyl)oxy]-5-methylidene-13-oxo-1h,2h,3h,3ah,4h,6h,7h,8h-cyclopenta[12]annulen-8-yl pyridine-3-carboxylate
3-[(2s,5s,11s,14s)-5,11,14-tribenzyl-6,9,15,18-tetrahydroxy-4,13-dimethyl-3,12-dioxo-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),6,9,15-tetraen-2-yl]propanimidic acid
C38H45N7O7 (711.3380299999999)
2-{[(1-{[2-(2-amino-n-methylpropanamido)-1-({[4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]amino}-3-(1h-indol-3-yl)propanoic acid
C32H41N9O10 (711.2976246000001)
2-{[(1-{[2-(2-amino-n-methylpropanamido)-1-({[(2z)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}ethyl)-c-hydroxycarbonimidoyl]amino}-3-(1h-indol-3-yl)propanoic acid
C32H41N9O10 (711.2976246000001)
(2s)-2-({[(1s)-1-{[(1s,2s)-2-[(2s)-2-amino-n-methylpropanamido]-1-({[(2z,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-ylidene]methyl}-c-hydroxycarbonimidoyl)propyl]-c-hydroxycarbonimidoyl}ethyl]-c-hydroxycarbonimidoyl}amino)-3-(1h-indol-3-yl)propanoic acid
C32H41N9O10 (711.2976246000001)
(7e,13e,15e,17e,19e)-21-[(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy]-12-ethyl-1,3,5,6,25-pentahydroxy-11-methyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid
(7s,9e,11s,12r,13s,14r,15r,16s,17r,18r,19e,21e)-2,15,17,18,23-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,27,29-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1⁴,⁷.0⁵,²⁸]triaconta-1,3,5(28),9,19,21,23,25-octaen-13-yl acetate
3-[5,11,14-tribenzyl-6,9,15,18-tetrahydroxy-4,13-dimethyl-3,12-dioxo-1,4,7,10,13,16-hexaazacyclooctadeca-1(18),6,9,15-tetraen-2-yl]propanimidic acid
C38H45N7O7 (711.3380299999999)